Programmatic and health outcomes by year
Year | 2020 | 2021 | 2022 | 2023 | 2024 | Total |
Emergency CS gap attributable to anaesthesia | 9248 | 9341 | 9434 | 9528 | 9624 | 47 175 |
Coverage scale-up | 13% | 38% | 63% | 88% | 100% | 61% |
Additional CS provided | 1202 | 3549 | 5943 | 8385 | 9624 | 28 704 |
Lives saved | ||||||
Maternal | 13 | 39 | 65 | 92 | 106 | 316 |
Fetal | 198 | 586 | 981 | 1384 | 1588 | 4736 |
Total | 212 | 625 | 1046 | 1476 | 1694 | 5052 |
Life-years gained | ||||||
Maternal | 646 | 1907 | 3193 | 4504 | 5170 | 15 419 |
Newborn | 13 222 | 39 034 | 65 362 | 92 212 | 105 834 | 315 664 |
Total | 13 867 | 40 941 | 68 554 | 96 716 | 111 004 | 331 083 |
Economic outcomes | ||||||
ESMK programme | US$149 328 | US$248 343 | US$258 118 | US$286 753 | US$237 188 | US$1 179 730 |
Additional CS | US$219 791 | US$648 892 | US$1 086 553 | US$1 532 902 | US$1 759 353 | US$5 247 491 |
CS share of total cost | 60% | 72% | 81% | 84% | 88% | 82% |
Total cost | US$369 119 | US$897 235 | US$1 344 671 | US$1 819 655 | US$1 996 541 | US$6 427 221 |
Base case, undiscounted.
CS, emergency caesarean; ESMK, Every Second Matters- Ketamine.